Browsing by Author Feng, Mei

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2019The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in miceWang, Yurong; Sun, Lie; Chen, Shanwen; Guo, Shihao; Yue, Taohua; Hou, Qisheng; Feng, Mei; Xu, Hao; Liu, Yucun; Wang, Pengyuan; Pan, Yisheng
9-Feb-2023The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinomaFeng, Mei; Xu, Hao; Zhou, Wenyuan; Pan, Yisheng
Oct-2021The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaTang, Ling-Long; Chen, Yu-Pei; Chen, Chuan-Ben; Chen, Ming-Yuan; Chen, Nian-Yong; Chen, Xiao-Zhong; Du, Xiao-Jing; Fang, Wen-Feng; Feng, Mei; Gao, Jin; Han, Fei; He, Xia; Hu, Chao-Su; Hu, De-sheng; Hu, Guang-Yuan; Jiang, Hao; Jiang, Wei; Jin, Feng; Lang, Jin-Yi; Li, Jin-Gao; Lin, Shao-Jun; Liu, Xu; Liu, Qiu-Fang; Ma, Lin; Mai, Hai-Qiang; Qin, Ji-Yong; Shen, Liang-Fang; Sun, Ying; Wang, Pei-Guo; Wang, Ren-Sheng; Wang, Ruo-Zheng; Wang, Xiao-Shen; Wang, Ying; Wu, Hui; Xia, Yun-Fei; Xiao, Shao-Wen; Yang, Kun-Yu; Yi, Jun-Lin; Zhu, Xiao-Dong; Ma, Jun
1-Mar-2022The protective effect of Escherichia coli Nissle 1917 on the intestinal barrier is mediated by inhibition of RhoA/ROCK2/MLC signaling via TLR-4Xu, Hao; Hou, Qisheng; Zhu, Jing; Feng, Mei; Wang, Pengyuan; Pan, Yisheng
2023A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinomaZhou, Wenyuan; Feng, Mei; Qi, Fei; Qiao, Jiao; Fan, Lina; Zhang, Long; Hu, Xuegang; Huang, Chunyu
2020Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in Hepatocellular CarcinomaDong, Xin; Feng, Mei; Yang, Hui; Liu, Hengkang; Guo, Hua; Gao, Xianshu; Liu, Yucun; Liu, Rong; Zhang, Ning; Chen, Ruibing; Kong, Ruirui
Oct-2023Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trialGao, Xiangyu; Xu, Nong; Li, Ziyu; Shen, Lin; Ji, Ke; Zheng, Zhong; Liu, Dan; Lou, Hanmei; Bai, Li; Liu, Tianshu; Li, Yunxia; Li, Yuzhi; Fan, Qingxia; Feng, Mei; Zhong, Haijun; Huang, Yi; Lou, Ge; Wang, Jing; Lin, Xiaoyan; Chen, Ye; An, Ruifang; Li, Changzheng; Zhou, Qi; Huang, Xin; Guo, Zengqing; Wang, Shubin; Li, Guiling; Fei, Junwei; Zhu, Lijing; Zhu, Hong; Li, Xiumin; Li, Fenghu; Liao, Sihai; Min, Qinghua; Tang, Lei; Shan, Fei; Gong, Jifang; Gao, Yunong; Zhou, Jun; Lu, Zhihao; Li, Xiaofan; Li, Jianjie; Ren, Hui; Liu, Xiaohong; Yang, Hongxia; Li, Wenting; Song, Weifeng; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Wu, Xiaohua; Ji, Jiafu
2019Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable PrognosisZhou, Jiangfan; Zheng, Xixi; Feng, Mei; Mo, Zhichao; Shan, Yunfeng; Wang, Yilin; Jin, Jing
23-May-2024YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axisQiao, Jiao; Feng, Mei; Zhou, Wenyuan; Tan, Yuan; Yang, Shuo; Liu, Qi; Wang, Qingchen; Feng, Weimin; Pan, Yisheng; Cui, Liyan